You are here: Industry Insights > Series C Funding

News List

NiKang Therapeutics secures $200m in Series C funding pharmaceutical-technology
May 28, 2021
NiKang Therapeutics has secured $200m in a Series C funding round to develop new small molecules for difficult-to-drug targets in oncology indications.
Numab Therapeutics secures $110m in Series C funding round pharmaceutical-technology
May 24, 2021
Numab Therapeutics has raised approximately $110m (CHF100m) through Series C funding to expedite the clinical development of its multi-specific antibody pipeline in oncology and inflammation.
GeneQuantum Raises Hundreds of Millions RMB in Series C Funding prnasia
May 19, 2021
GeneQuantum Healthcare (Suzhou) Co., Ltd. announced the completion of Series C fund raising of several hundreds of millions RMB.
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates prnasia
November 04, 2020
CARsgen Therapeutics Holdings Limited, a leading biotechnology company focused on innovation and development of chimeric antigen receptor (CAR) T-cell therapeutics, announced the completion of a USD 186 million Series C Equity Financing.
XtalPi raises $318m to support AI-based drug discovery pharmaceutical-technology
October 09, 2020
Artificial intelligence (AI)-based drug discovery company XtalPi has raised $318.8m in a Series C funding round co-led by SoftBank Vision Fund 2, PICC Capital and Morningside.
China's Huimei Technology receives $30 million in Series C funding biospectrumasia
September 04, 2019
Pharmaceutical firm WuXi AppTec and Huimei Capital, the investment arm of healthcare services provider Huimei Healthcare backed the series C round
Recursion Pharmaceuticals secures $121M in Series C funding biospectrumasia
July 17, 2019
The new financing will support Recursion’s continued build-out of its machine learning-enabled drug discovery platform alongside new capabilities designed to radically accelerate new chemical entity chemistry and predict safety pharmacology
Zymergen announces $400M in Series C Funding biospectrumasia
December 18, 2018
To achieve these results, Zymergen uses artificial intelligence algorithms and robotic genomic “factories” to search the microbial genome, running tens of thousands of experiments to spot subtle signals of improvement